APOG vs JNJ · P/E 15, rev $1.40B vs P/E 17, rev $49.37B
Apogee Enterprises Inc (APOG) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Apogee Enterprises Inc (APOG) is a building products & equipment company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported APOG revenue for 2026-02-28 was $1.40B. Net income was $54.1M. Revenue was up 3.2% from 2025-03-01 to 2026-02-28. APOG currently screens at market cap $797.9M and trailing P/E 14.8.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
APOG currently screens at market cap $797.9M and trailing P/E 14.8. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the APOG and JNJ stock pages for the full models.
Not investment advice.